US 12,351,816 · Application 18/363,453 · Granted Jul 8, 2025
US 12,351,816
Cns gene delivery using peripheral administration of aav vectors
Estimated expiration
July 22, 2028
1y 294d remaining
- Could not fetch continuity data for application PCTEP2008059595: Resource not found (404)
Earliest effective filing
Jul 22, 2008
+ 20 years
Jul 22, 2028
PTA +0d
Jul 22, 2028
TD applied
Jul 22, 2028
Final
Jul 22, 2028
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- August 1, 2023
- Earliest effective filing
- July 22, 2008
- Issue date
- July 8, 2025
- PTA
- 0 days
- Base expiry (before PTA)
- July 22, 2028
July 22, 2008 + 20 years = July 22, 2028
- Continuation of application 16/214,214, filed Dec 10, 2018
- Continuation of application 12/452,789, filed Jan 22, 2010, issued as US 10,208,318
- National stage entry of application PCTEP2008059595, filed Jul 22, 2008
- National stage entry of application PCTEP2008059595, filed Jul 22, 2008
- Continuation of application 12/452,789, filed Jan 22, 2010, issued as US 10,208,318
- National stage entry of application PCTEP2008059595, filed Jul 22, 2008
Terminal disclaimers
TD caps expiration to July 22, 2028
US 12,351,816· Application 18/363,453(from application 18/363,453)Capping patent
Cns gene delivery using peripheral administration of aav vectors
- Filing date
- Aug 1, 2023
- Earliest effective filing
- Jul 22, 2008
- Issue date
- Jul 8, 2025
- PTA
- 0 days
- Calculated expiration
- Jul 22, 2028
Continuation of 16/214,214, filed Dec 10, 2018
Continuation of 12/452,789, filed Jan 22, 2010, issued as US 10,208,318
National stage entry of PCTEP2008059595, filed Jul 22, 2008
National stage entry of PCTEP2008059595, filed Jul 22, 2008
Continuation of 12/452,789, filed Jan 22, 2010, issued as US 10,208,318
National stage entry of PCTEP2008059595, filed Jul 22, 2008
Jul 22, 2008 + 20y = Jul 22, 2028
US 10,208,318· Application 12/452,789
Cns gene delivery using peripheral administration of aav vectors
- Filing date
- Jan 22, 2010
- Earliest effective filing
- Jul 22, 2008
- Issue date
- Feb 19, 2019
- PTA
- 0 days
- Calculated expiration
- Jul 22, 2028
National stage entry of PCTEP2008059595, filed Jul 22, 2008
Jul 22, 2008 + 20y = Jul 22, 2028
US 9,926,574· Application 12/734,016
Widespread gene delivery to motor neurons using peripheral injection of aav vectors
- Filing date
- May 28, 2010
- Earliest effective filing
- Oct 3, 2008
- Issue date
- Mar 27, 2018
- PTA
- +158 days
- Calculated expiration
- Mar 10, 2029
National stage entry of PCTEP2008063297, filed Oct 3, 2008
Oct 3, 2008 + 20y + 158d PTA = Mar 10, 2029
US 11,767,538· Application 16/536,503
Widespread gene delivery to motor neurons using peripheral injection of aav vectors
- Filing date
- Aug 9, 2019
- Earliest effective filing
- Oct 3, 2008
- Issue date
- Sep 26, 2023
- PTA
- 0 days
- Calculated expiration
- Oct 3, 2028
Divisional of 15/713,347, filed Sep 22, 2017
Divisional of 12/734,016, filed May 28, 2010, issued as US 9,926,574
National stage entry of PCTEP2008063297, filed Oct 3, 2008
National stage entry of PCTEP2008063297, filed Oct 3, 2008
Divisional of 12/734,016, filed May 28, 2010, issued as US 9,926,574
National stage entry of PCTEP2008063297, filed Oct 3, 2008
Oct 3, 2008 + 20y = Oct 3, 2028
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 18/363,453 · US 12,351,816
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 12,351,816: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US12351816Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.